Format

Send to

Choose Destination
Oncotarget. 2016 Jun 21;7(25):37944-37956. doi: 10.18632/oncotarget.9272.

Piwi-interacting RNAs and PIWI genes as novel prognostic markers for breast cancer.

Author information

1
Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
2
Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.
3
Cross Cancer Institute, Alberta Health Services, Edmonton, Alberta, Canada.
4
Department of Biological Sciences, University of Lethbridge, Lethbridge, Alberta, Canada.

Abstract

Piwi-interacting RNAs (piRNAs), whose role in germline maintenance has been established, are now also being classified as post-transcriptional regulators of gene expression in somatic cells. PIWI proteins, central to piRNA biogenesis, have been identified as genetic and epigenetic regulators of gene expression. piRNAs/PIWIs have emerged as potential biomarkers for cancer but their relevance to breast cancer has not been comprehensively studied. piRNAs and mRNAs were profiled from normal and breast tumor tissues using next generation sequencing and Agilent platforms, respectively. Gene targets for differentially expressed piRNAs were identified from mRNA expression dataset. piRNAs and PIWI genes were independently assessed for their prognostic significance (outcomes: Overall Survival, OS and Recurrence Free Survival, RFS). We discovered eight piRNAs as novel independent prognostic markers and their association with OS was confirmed in an external dataset (The Cancer Genome Atlas). Further, PIWIL3 and PIWIL4 genes showed prognostic relevance. 306 gene targets exhibited reciprocal relationship with piRNA expression. Cancer cell pathways such as apoptosis and cell signaling were the key Gene Ontology terms associated with the regulated gene targets. Overall, we have captured the entire cascade of events in a dysregulated piRNA pathway and have identified novel markers for breast cancer prognostication.

KEYWORDS:

PIWI; TCGA; breast cancer; piRNA; prognostic marker

PMID:
27177224
PMCID:
PMC5122362
DOI:
10.18632/oncotarget.9272
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Impact Journals, LLC Icon for PubMed Central
Loading ...
Support Center